Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Health Policy,Pharmacology
Reference29 articles.
1. Bach PB. Indication-specific pricing for cancer drugs. JAMA. 2014;312(16):1629–30.
2. Saiyed M, Ong P, Chew L. Off-label drug use in oncology: a systematic review of literature. J Clin Pharm Ther. 2017;42(3):251–8. https://doi.org/10.1111/jcpt.12507.
3. Aitken M, Kleinrock M, Simorellis A, Nass D (2018) Global oncology trends 2018, innovation, expansion and disruption. [online] IQVIA Institute for Human Data Science. Available at: https://www.iqvia.com/- /media/iqvia/pdfs/institute-reports/global-oncology-trends-2018.pdf
4. Schein CH. Repurposing approved drugs for cancer therapy. Br Med Bull. 2021;137(1):13–27.
5. Hernandez JJ, Pryszlak M, Smith L, Yanchus C, Kurji N, Shahani VM, Molinski SV. Giving drugs a second chance: overcoming regulatory and financial hurdles in repurposing approved drugs as cancer therapeutics. Front Oncol. 2017;7:273.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献